GB201620516D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB201620516D0 GB201620516D0 GBGB1620516.3A GB201620516A GB201620516D0 GB 201620516 D0 GB201620516 D0 GB 201620516D0 GB 201620516 A GB201620516 A GB 201620516A GB 201620516 D0 GB201620516 D0 GB 201620516D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1620516.3A GB201620516D0 (en) | 2016-12-02 | 2016-12-02 | Pharmaceutical composition |
| ES17777634T ES2891579T3 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| CN202310227306.XA CN116270640A (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| CN201780057065.1A CN109715160A (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| MX2019003105A MX387725B (en) | 2016-09-19 | 2017-09-18 | PHARMACEUTICAL COMPOSITION. |
| CA3037080A CA3037080C (en) | 2016-09-19 | 2017-09-18 | Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis) |
| US16/334,151 US11260052B2 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| CN202110262649.0A CN113288869A (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| ES21183138T ES2949975T3 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition comprising indacaterol |
| AU2017328905A AU2017328905C1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| PCT/GB2017/052757 WO2018051128A1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| EP17777634.1A EP3515441B1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition comprising indacaterol |
| EP21183138.3A EP3909582B1 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition comprising indacaterol |
| JP2019515269A JP6781830B2 (en) | 2016-09-19 | 2017-09-18 | Pharmaceutical composition |
| BR112019005080-9A BR112019005080B1 (en) | 2016-09-19 | 2017-09-18 | PHARMACEUTICAL COMPOSITION, METERED-DOSE INHALER, AND METHODS FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION, FOR INCREASING THE STABILIZATION TIME OF A PHARMACEUTICAL COMPOSITION AND FOR IMPROVING THE AEROSOLIZATION PERFORMANCE OF A PHARMACEUTICAL COMPOSITION |
| MX2021010022A MX2021010022A (en) | 2016-09-19 | 2019-03-15 | Pharmaceutical composition. |
| AU2020202580A AU2020202580B2 (en) | 2016-09-19 | 2020-04-16 | Pharmaceutical composition |
| JP2020140692A JP6972256B2 (en) | 2016-09-19 | 2020-08-24 | Pharmaceutical composition |
| US17/577,824 US20220133709A1 (en) | 2016-09-19 | 2022-01-18 | Pharmaceutical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1620516.3A GB201620516D0 (en) | 2016-12-02 | 2016-12-02 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201620516D0 true GB201620516D0 (en) | 2017-01-18 |
Family
ID=58159709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1620516.3A Ceased GB201620516D0 (en) | 2016-09-19 | 2016-12-02 | Pharmaceutical composition |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201620516D0 (en) |
-
2016
- 2016-12-02 GB GBGB1620516.3A patent/GB201620516D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265260B (en) | Pharmaceutical composition | |
| IL265360A (en) | Pharmaceutical composition | |
| IL262654A (en) | Pharmaceutical composition | |
| IL271986A (en) | Pharmaceutical composition | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201712159D0 (en) | Pharmaceutical composition | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| PL3583943T3 (en) | Pharmaceutical composition | |
| IL272419A (en) | Pharmaceutical composition | |
| GB201719447D0 (en) | Pharmaceutical composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| PL3646867T3 (en) | Pharmaceutical composition | |
| PL3454838T3 (en) | Pharmaceutical composition | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| IL263999A (en) | Pharmaceutical compositions | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| IL265436B (en) | Pharmaceutical composition | |
| ZA201705782B (en) | Pharmaceutical compositions | |
| PL3424500T3 (en) | Pharmaceutical composition comprising famitinib | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| IL265428A (en) | Pharmaceutical composition | |
| PT3476391T (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |